<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[NOVO — August 2022]]></title><description><![CDATA[<p dir="auto">Fra Berlingske: Opjustering på vej hos Novo Nordisk?</p>
<p dir="auto">Tirsdag leverede Mærsk en opjustering, og analytikerne forudser nu, at Novo Nordisk snart vil gøre dem kunsten efter. Det skriver Børsen.</p>
<p dir="auto">Forud for medicinalgigantens regnskab på torsdag er forventningerne nemlig høje, og flere analytikere regner med, at 2022 bliver bedre, end ledelsen allerede har meldt ud.</p>
]]></description><link>https://dev.proinvestor.com/forum/topic/400288/novo-august-2022</link><generator>RSS for Node</generator><lastBuildDate>Sat, 06 Jun 2026 22:17:10 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/400288.rss" rel="self" type="application/rss+xml"/><pubDate>Wed, 03 Aug 2022 04:21:51 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to NOVO — August 2022 on Wed, 24 Aug 2022 11:58:56 GMT]]></title><description><![CDATA[<p dir="auto">Der er fart på i dag:-)</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978266</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978266</guid><dc:creator><![CDATA[AaBforever]]></dc:creator><pubDate>Wed, 24 Aug 2022 11:58:56 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — August 2022 on Wed, 24 Aug 2022 03:43:36 GMT]]></title><description><![CDATA[<p dir="auto">Fra debatten: <a href="https://www.proinvestor.com/boards/105488/" rel="nofollow ugc">https://www.proinvestor.com/boards/105488/</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978265</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978265</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Wed, 24 Aug 2022 03:43:36 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — August 2022 on Wed, 24 Aug 2022 02:59:50 GMT]]></title><description><![CDATA[<p dir="auto">Onsdagens aviser med Novo Nordisk, Sydbank og Danfoss <a href="https://www.proinvestor.com/investornyt/870502/onsdagens-aviser-med-novo-nordisk-sydbank-og-danfoss" rel="nofollow ugc">https://www.proinvestor.com/investornyt/870502/onsdagens-aviser-med-novo-nordisk-sydbank-og-danfoss</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978263</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978263</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Wed, 24 Aug 2022 02:59:50 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — August 2022 on Tue, 23 Aug 2022 03:20:27 GMT]]></title><description><![CDATA[<p dir="auto">USD ikke set stærkere i 20 år er gode nyheder for Novo <a href="https://www.proinvestor.com/boards/105499" rel="nofollow ugc">https://www.proinvestor.com/boards/105499</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978262</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978262</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 23 Aug 2022 03:20:27 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — August 2022 on Mon, 22 Aug 2022 11:09:17 GMT]]></title><description><![CDATA[<p dir="auto">Dejligt...:-)</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978259</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978259</guid><dc:creator><![CDATA[AaBforever]]></dc:creator><pubDate>Mon, 22 Aug 2022 11:09:17 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — August 2022 on Mon, 22 Aug 2022 10:46:29 GMT]]></title><description><![CDATA[<p dir="auto">Novo Nordisk-aktien kraftigt i vejret efter "meget stærke resultater". <a href="https://www.proinvestor.com/investornyt/869508/novo-nordisk-aktien-kraftigt-i-vejret-efter-meget-staerke-resultater" rel="nofollow ugc">https://www.proinvestor.com/investornyt/869508/novo-nordisk-aktien-kraftigt-i-vejret-efter-meget-staerke-resultater</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978260</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978260</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 22 Aug 2022 10:46:29 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — August 2022 on Mon, 22 Aug 2022 10:32:07 GMT]]></title><description><![CDATA[<p dir="auto">Nydelig stigning</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978257</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978257</guid><dc:creator><![CDATA[Bulder]]></dc:creator><pubDate>Mon, 22 Aug 2022 10:32:07 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — August 2022 on Mon, 22 Aug 2022 10:08:40 GMT]]></title><description><![CDATA[<p dir="auto">Novo Nordisk successfully completes phase 2 trial with CagriSema in people with type 2 diabetes <a href="https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=131155" rel="nofollow ugc">https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=131155</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978256</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978256</guid><dc:creator><![CDATA[Bulder]]></dc:creator><pubDate>Mon, 22 Aug 2022 10:08:40 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — August 2022 on Mon, 22 Aug 2022 03:06:15 GMT]]></title><description><![CDATA[<p dir="auto">Mandagens aviser med SAS, FLSmidth og Novo Nordisk <a href="https://www.proinvestor.com/investornyt/869397/mandagens-aviser-med-sas-flsmidth-og-novo-nordisk" rel="nofollow ugc">https://www.proinvestor.com/investornyt/869397/mandagens-aviser-med-sas-flsmidth-og-novo-nordisk</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978258</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978258</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Mon, 22 Aug 2022 03:06:15 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — August 2022 on Mon, 22 Aug 2022 03:05:46 GMT]]></title><description><![CDATA[<p dir="auto">Test</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978255</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978255</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Mon, 22 Aug 2022 03:05:46 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — August 2022 on Sat, 13 Aug 2022 05:38:13 GMT]]></title><description><![CDATA[<p dir="auto">Det er nok der hunden ligger begravet.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978264</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978264</guid><dc:creator><![CDATA[Bulder]]></dc:creator><pubDate>Sat, 13 Aug 2022 05:38:13 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — August 2022 on Sat, 13 Aug 2022 05:01:55 GMT]]></title><description><![CDATA[<p dir="auto">ANALYSIS-U.S. move to negotiate drug prices a rare defeat for Big Pharma <a href="https://www.proinvestor.com/investornyt/866377/analysis-us-move-to-negotiate-drug-prices-a-rare-defeat-for-big-pharma" rel="nofollow ugc">https://www.proinvestor.com/investornyt/866377/analysis-us-move-to-negotiate-drug-prices-a-rare-defeat-for-big-pharma</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978251</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978251</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Sat, 13 Aug 2022 05:01:55 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — August 2022 on Sat, 13 Aug 2022 01:47:42 GMT]]></title><description><![CDATA[<p dir="auto">Reduction Inflation Act..gik igennem I USA.. medicare og cap on Insulin spend.. bla. Kan ikke gennemskue om det betyder noget med det samme. Men der er åbnet op for at Medicare kan forhandle bulk ( vs alle de private selskaber, som suger kæmpe profitter så novo går ned i pris men forbrugerne betaler stadig kassen).. der var et par ændringer i sidste øjeblik.. man kan ikke finde detaillierne, så svært at se hvad det evt kan betyde alt i alt)</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978252</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978252</guid><dc:creator><![CDATA[Jazzz]]></dc:creator><pubDate>Sat, 13 Aug 2022 01:47:42 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — August 2022 on Fri, 12 Aug 2022 12:53:54 GMT]]></title><description><![CDATA[<p dir="auto">Nej, det var bare at faldet kl 13 var meget brat og bragte mindelser om forleden.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978253</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978253</guid><dc:creator><![CDATA[Bulder]]></dc:creator><pubDate>Fri, 12 Aug 2022 12:53:54 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — August 2022 on Fri, 12 Aug 2022 12:13:36 GMT]]></title><description><![CDATA[<p dir="auto">Ex dividende igår,<br />
er det eneste jeg kan se</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978249</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978249</guid><dc:creator><![CDATA[Jazzz]]></dc:creator><pubDate>Fri, 12 Aug 2022 12:13:36 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — August 2022 on Fri, 12 Aug 2022 12:13:03 GMT]]></title><description><![CDATA[<p dir="auto">2% som jeg kan se det.. det er vel ikke noget.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978254</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978254</guid><dc:creator><![CDATA[Jazzz]]></dc:creator><pubDate>Fri, 12 Aug 2022 12:13:03 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — August 2022 on Fri, 12 Aug 2022 09:47:45 GMT]]></title><description><![CDATA[<p dir="auto">Markant fra kl ca 13</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978261</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978261</guid><dc:creator><![CDATA[Bulder]]></dc:creator><pubDate>Fri, 12 Aug 2022 09:47:45 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — August 2022 on Fri, 12 Aug 2022 09:45:09 GMT]]></title><description><![CDATA[<p dir="auto">Nogen der ved hvorfor novo dykker?</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978250</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978250</guid><dc:creator><![CDATA[Bulder]]></dc:creator><pubDate>Fri, 12 Aug 2022 09:45:09 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — August 2022 on Thu, 11 Aug 2022 11:04:07 GMT]]></title><description><![CDATA[<p dir="auto">Kort video: Varmen fortsætter - også på aktiemarkedet. Bl.a. ser vi en positiv reaktion på, at inflationen i juni i USA ikke blev så stor som ventet.<br />
Helge Larsen ser i denne uge også på nogle af <a href="http://ProInvestor.com" rel="nofollow ugc">ProInvestor.com</a>'s populære aktier: Genmab, som opjusterer, Novo Nordisk fik høvl i sidste uge, Vestas kom med negativt regnskab, men steg i kurs onsdag, og så er der Bavarian Nordic, der ligger til en meget høj kurs. <a href="https://www.proinvestor.com/boards/105203" rel="nofollow ugc">https://www.proinvestor.com/boards/105203</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978248</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978248</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Thu, 11 Aug 2022 11:04:07 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — August 2022 on Tue, 09 Aug 2022 12:37:38 GMT]]></title><description><![CDATA[<p dir="auto">Four new products will help Novo Nordisk division grow<br />
<a href="https://medwatch.com/News/Pharma___Biotech/article14294034.ece" rel="nofollow ugc">https://medwatch.com/News/Pharma___Biotech/article14294034.ece</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978245</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978245</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 09 Aug 2022 12:37:38 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — August 2022 on Mon, 08 Aug 2022 13:58:13 GMT]]></title><description><![CDATA[<p dir="auto">Novo-bestyrelsesmedlem køber 250 ADR-aktier<br />
<a href="https://www.proinvestor.com/investornyt/863241/novo-bestyrelsesmedlem-kober-250-adr-aktier" rel="nofollow ugc">https://www.proinvestor.com/investornyt/863241/novo-bestyrelsesmedlem-kober-250-adr-aktier</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978241</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978241</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 08 Aug 2022 13:58:13 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — August 2022 on Mon, 08 Aug 2022 09:17:10 GMT]]></title><description><![CDATA[<p dir="auto">Pfizer laver milliardkøb af tidligere Novo-opkøbsmål<br />
<a href="https://www.proinvestor.com/investornyt/863023/pfizer-laver-milliardkob-af-tidligere-novo-opkobsmal" rel="nofollow ugc">https://www.proinvestor.com/investornyt/863023/pfizer-laver-milliardkob-af-tidligere-novo-opkobsmal</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978246</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978246</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 08 Aug 2022 09:17:10 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — August 2022 on Fri, 05 Aug 2022 11:31:04 GMT]]></title><description><![CDATA[<p dir="auto">Novo/Nykredit: Anbefaling hæves til "køb" fra "hold"<br />
<a href="https://www.proinvestor.com/investornyt/862280/novo-nykredit-anbefaling-haeves-til-kob-fra-hold" rel="nofollow ugc">https://www.proinvestor.com/investornyt/862280/novo-nykredit-anbefaling-haeves-til-kob-fra-hold</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978244</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978244</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 05 Aug 2022 11:31:04 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — August 2022 on Fri, 05 Aug 2022 09:36:15 GMT]]></title><description><![CDATA[<p dir="auto">Novo/Sydbank: Lillys effektsammenligning vil øge konkurrence og marked<br />
<a href="https://www.proinvestor.com/investornyt/862204/novo-sydbank-lillys-effektsammenligning-vil-oge-konkurrence-og-marked" rel="nofollow ugc">https://www.proinvestor.com/investornyt/862204/novo-sydbank-lillys-effektsammenligning-vil-oge-konkurrence-og-marked</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978240</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978240</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 05 Aug 2022 09:36:15 GMT</pubDate></item></channel></rss>